Fortress Biotech Inc
NASDAQ:FBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fortress Biotech Inc
NASDAQ:FBIO
|
US |
|
P
|
Premier Foods PLC
F:FOJ1
|
UK |
|
A
|
Amcor PLC
XBER:485
|
UK |
|
A
|
Aytu Biopharma Inc
F:AY20
|
US |
|
P
|
Popular Inc
F:PP4A
|
PR |
|
Apple Inc
NASDAQ:AAPL
|
US |
|
Gen Digital Inc
NASDAQ:GEN
|
US |
|
EVgo Inc
NASDAQ:EVGO
|
US |
|
Pilot Corp
TSE:7846
|
JP |
|
InPlay Oil Corp
F:8DA
|
CA |
|
G
|
Gamuda Bhd
KLSE:GAMUDA
|
MY |
|
TuSimple Holdings Inc
OTC:TSPH
|
US |
|
C
|
Currys PLC
OTC:DSITF
|
UK |
|
Eiffage SA
PAR:FGR
|
FR |
|
C
|
Commercial Metals Co
SWB:CMS
|
US |
|
B
|
Baltic Classifieds Group PLC
F:983
|
UK |
|
Shift4 Payments Inc
NYSE:FOUR
|
US |
|
Saturn Oil & Gas Inc
XTSX:SOIL
|
CA |
|
A
|
Anima Holding SpA
F:124
|
IT |
Wall St Price Targets
FBIO Price Targets Summary
Fortress Biotech Inc
According to Wall Street analysts, the average 1-year price target for
FBIO is 11.22 USD with a low forecast of 5.05 USD and a high forecast of 17.85 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FBIO's stock price target?
Price Target
11.22
USD
According to Wall Street analysts, the average 1-year price target for
FBIO is 11.22 USD with a low forecast of 5.05 USD and a high forecast of 17.85 USD.
What is the Revenue forecast for Fortress Biotech Inc?
Projected CAGR
47%
The compound annual growth rate for Revenue over the next 2 years is 47%.
What is the Gross Profit forecast for Fortress Biotech Inc?
Projected CAGR
63%
The compound annual growth rate for Gross Profit over the next 2 years is 63%.